Global Low Molecular Weight Heparin Market - Industry Analysis, Market Trends,

1. Low Molecular Weight Heparin Market Global Analysis and Forecast to 2028 Published Date : Dec 2021 Email: sales@theinsightpartners.com

2. Email: sales@theinsightpartners.com Report Studies  Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application [Deep Vein Thrombosis, Acute Coronary Syndrome (ACS), Pulmonary Embolism, and Others], and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography 2

3. Email: sales@theinsightpartners.com Low Molecular Weight Heparin Market Overview  The low molecular weight heparin market is expected to grow from US$ 3,658.27 million in 2021 to US$ 5,733.96 million by 2028; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028.  Low molecular weight heparin (LMWH) is a class of anticoagulants. They are used to prevent blood clots and to treat venous thromboembolism (deep vein thrombosis and pulmonary embolism) and treat myocardial infarction. LMWHs are defined as heparin salts with an average molecular weight of less than 8,000 Da and in which at least 60% of all chains have a molecular weight of less than 8,000 Da. These are obtained by various methods of fractionation or depolymerization of polymeric heparin. Low molecular weight heparin offers advantages over heparin in that it has better bioavailability and longer half-life, simplified dosing, predictable anticoagulant response, lower risk of HIT, and lower risk of osteoporosis. 3

4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others)  Application (Deep Vein Thrombosis, Acute Coronary Syndrome (ACS), Pulmonary Embolism, and Others)  End-User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others) Download Sample Here 4

5. Email: sales@theinsightpartners.com Low Molecular Weight Heparin Market Value $50,000 $40,000 $30,000 CAGR of 6.6% $20,000 (2021 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

6. Email: sales@theinsightpartners.com Company Profiles  Aspen Holdings  Changzhou Qianhong Bio-Pharma  LeopharmaA/S  Teva Pharmaceutical Industries Ltd.  B. Braun Medical, Inc.  Pfizer, Inc.  Sanofi  Dr. Reddy's Laboratories Limited  Abbott  Novartis AG Download Sample Here 6

7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com